In 2023, mortality due to Genitourinary System Diseases among females in the US stood at a certain baseline. The forecast data from 2024 to 2028 shows a consistent upward trend, increasing from 41.23 to 43.65 thousand female deaths. This represents a year-on-year increase of approximately 1.48% from 2024 to 2025, followed by similar increments of around 1.45% annually thereafter. The compound annual growth rate (CAGR) over this period is about 1.44%, indicating a steady rise in mortality rates.
Future trends to watch for include potential impacts from advancements in medical treatments and healthcare policies which could alter these projections. Demographic changes, such as an aging population, may also influence mortality rates. Monitoring these factors could provide insights into future mortality trends in genitourinary diseases.
